Magnetic Particle Imaging Angiography for Chronic Kidney Disease Patients
$378,857R01FY2013EBNIH
University Of California Berkeley, Berkeley CA
Investigators
Linked publications, trials & patents
Paper 32557879Paper 29990139Paper 29165498Paper 28742047Paper 28177301Paper 28059427Paper 27867219Paper 27686629Paper 26909106Paper 26745935Paper 26636133Paper 26618195Paper 26586919Paper 26495839Paper 26412614Paper 26390044Paper 26358296Paper 26127053Paper 26059262Paper 26023242Paper 25818431Paper 25729125Paper 25554710Paper 25473124Paper 25438306Paper 24753632Paper 24633522Paper 23940058Paper 23822441Paper 23787461Paper 23649181Paper 23568496Paper 23434348Paper 23305842Paper 23193308Paper 22988557Paper 22968211Paper 22552332Paper 22462930Paper 22213652Paper 21402508Patent 9555136Patent 11204398Patent 10775452
Abstract
DESCRIPTION (provided by applicant): We will develop hardware, software and novel contrast agents for a new angiographic imaging modality called Magnetic Particle Imaging, which is completely different from X-ray, CT and MRI. Currently available angiographic contrast agents (iodine for X-ray and gadolinium for MRI) are dangerous for Chronic Kidney Disease patients. Magnetic Particle Imaging offers excellent image quality and the contrast agents are completely safe for Chronic Kidney Disease patients. This research will remove the final obstacles to a major medical breakthrough for Chronic Kidney Disease patients.
View original record on NIH RePORTER →